Astrana Health (ASTH) ex-officer surrenders 11,793 unvested shares on retirement

Rhea-AI Filing Summary

Astrana Health, Inc. reported that former officer Glenn Sobotka surrendered 11,793 shares of unvested time-based and performance-based restricted common stock in a disposition to the issuer in connection with his retirement. Following this forfeiture, he holds 2,246 shares, including 1,300 restricted shares that will vest on an accelerated basis subject to his execution of a release of claims.

Insider Trade Summary

Net Seller: 11,793 shares

Net Sell 1 txn

Insider Sobotka Glenn

Role Insider

Type	Security	Shares	Price	Value
Disposition	Common Stock F1, F2	11,793	$0.00	$0.00

Holdings After Transaction: Common Stock — 2,246 shares (Direct)

Footnotes (2)

1. F1. Represents the surrender of unvested time-based and performance-based restricted stock that was forfeited in connection with the reporting person's retirement from his positions with the Issuer.
2. F2. Includes 1,300 shares of restricted stock that will vest on an accelerated basis in connection with the reporting person's retirement from his positions with the Issuer, subject to his execution of a release of claims.

Key Figures

Shares disposed: 11,793 shares Price per share: $0.00 Shares held after transaction: 2,246 shares +1 more

4 metrics

Shares disposed 11,793 shares Unvested restricted stock surrendered to issuer upon retirement

Price per share $0.00 Reported value for disposition to issuer of unvested restricted stock

Shares held after transaction 2,246 shares Directly owned by Glenn Sobotka following forfeiture

Accelerated vesting restricted shares 1,300 shares Restricted stock that will vest on an accelerated basis, conditional on release of claims

Key Terms

restricted stock, disposition to issuer, accelerated basis

3 terms

restricted stock financial

"Represents the surrender of unvested time-based and performance-based restricted stock"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

disposition to issuer financial

"transaction_code_description: Disposition to issuer"

accelerated basis financial

"shares of restricted stock that will vest on an accelerated basis"

FAQ

What insider transaction did Astrana Health (ASTH) report for Glenn Sobotka?

Astrana Health reported that former officer Glenn Sobotka surrendered 11,793 shares of unvested restricted common stock to the issuer in connection with his retirement, a non-market disposition.

How many Astrana Health (ASTH) shares did Glenn Sobotka dispose of?

Glenn Sobotka disposed of 11,793 shares of Astrana Health common stock. These were unvested time-based and performance-based restricted stock forfeited back to the company upon his retirement.

How many Astrana Health (ASTH) shares does Glenn Sobotka hold after this transaction?

After the transaction, Glenn Sobotka directly holds 2,246 shares of Astrana Health common stock. This amount includes 1,300 restricted shares scheduled to vest on an accelerated basis, subject to a release of claims.

Was Glenn Sobotka’s Astrana Health (ASTH) share disposition a market sale?

No. The filing describes the transaction as a disposition to the issuer, representing surrender of unvested restricted stock in connection with retirement, with a reported price per share of $0.00.

What happens to Glenn Sobotka’s remaining restricted Astrana Health (ASTH) shares?

Of his remaining holdings, 1,300 shares are restricted stock that will vest on an accelerated basis in connection with his retirement, contingent on his execution of a release of claims.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/11/2026 - 05:10 PM Accepted by SEC EDGAR 08/11/2026 - 05:09 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sobotka Glenn

(Last) (First) (Middle)

C/O ASTRANA HEALTH, INC.

1668 S. GARFIELD AVENUE, 2ND FLOOR

(Street)

ALHAMBRA CALIFORNIA 91801

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Astrana Health, Inc. [ ASTH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
			Former Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/07/2026		D		11,793(1)	D	$0	2,246(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the surrender of unvested time-based and performance-based restricted stock that was forfeited in connection with the reporting person's retirement from his positions with the Issuer.

2. Includes 1,300 shares of restricted stock that will vest on an accelerated basis in connection with the reporting person's retirement from his positions with the Issuer, subject to his execution of a release of claims.

	/s/ Kathy Diep, as Attorney-in-Fact	08/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)